PRKCD and diabetic foot: From our study, we may conclude that the inhibition of the PKCδ-HMGCS1/HMGCR pathway alleviates high glucose-induced endothelial apoptosis and represent a potential therapeutic strategy for diabetic foot ulcers [46].